Bio-Rad Laboratories (BIO) EBIT Growth (3y) (2012 - 2026)
Bio-Rad Laboratories (BIO) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bio-Rad Laboratories | 8.53 Bn | 6.97 Bn | 309.40 Mn | -18.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.03% |
| Dec 31, 2025 | -44.26% |
| Sep 30, 2025 | -11.64% |
| Jun 30, 2025 | -14.39% |
| Mar 31, 2025 | -45.50% |
| Dec 31, 2024 | -20.92% |
| Sep 30, 2024 | -25.63% |
| Jun 30, 2024 | -6.65% |
| Mar 31, 2024 | -23.82% |
| Dec 31, 2023 | -19.92% |
| Sep 30, 2023 | -6.03% |
| Jun 30, 2023 | 20.09% |
| Mar 31, 2023 | -5.93% |
| Dec 31, 2022 | 26.08% |
| Sep 30, 2022 | 18.10% |
| Jun 30, 2022 | 29.65% |
| Mar 31, 2022 | 37.27% |
| Dec 31, 2021 | 36.07% |
| Sep 30, 2021 | 62.90% |
| Jun 30, 2021 | 41.77% |